OncoAdvisor™
Your AI Companion in Precision Oncology
The platform is designed to transform
cancer care by combining multi-omics
intelligence with clinical decision-
making. It leverages advanced
computational analytics to extract
insights from genomic, epigenetic,
proteomic , and metabolomic data
—enabling truly personalised
treatment strategies and improved
patient outcomes.
How will Precimmo help us fight cancer?
Multi-Omics Data Intelligence:
Aggregates biomarker information from genomic sequencing (NGS), epigenetic modifications, protein expression analysis, and metabolic profiling.
Enhances diagnostic precision by correlating molecular signatures with cancer progression and therapeutic response.
AI-Driven Clinical Insights:
Uses machine learning algorithms to analyze tumor profiles and predict therapy responses.
Assesses prior medical history, TNM staging, and compliance with NCCN/ASCO/ESMO guidelines to personalize treatment recommendations.
Compliance & Decision Support:
Evaluates treatment plans against global oncology standards, ensuring regulatory and clinical best practices.
Supports evidence-based medicine through continuous learning from global cancer data.
Metabolomics
Electronic Health Records
Proteomics
Epigenomics
Genomics
Impact on Oncology Practice
OncoAdvisor™ empowers clinicians with data-
driven insights to improve patient outcomes,
reduce treatment resistance, & optimise
cancer care. Through integration with
electronic health records (EHRs) and multi-
omics analytics, the platform supports:
- Early detection ->
- Precision treatment planning ->
- Monitoring treatment response ->
Personalised Therapy Selection
Guides oncologists in selecting optimal treatment strategies, including targeted chemotherapy, immunotherapy, cell therapies & gene therapy/vaccines.
Identifies relevant clinical trials for patients based on their tumor biomarkers & eligibility
